Blood Product Conservation is Associated with Improved Outcomes and Reduced Costs after Cardiac Surgery
The purpose of this investigation was to determine whether a multi-institutional effort to reduce blood product use affects postoperative events aftercardiac surgical operations and to determine the influence of perioperative transfusion on risk-adjusted outcomes.
The Predictive Value of Multiple Electrode Platelet Aggregometry (Multiplate) in Adult Cardiac Surgery
The purpose of this retrospective observational study is to analyze the value of multiple electrode platelet aggregometry (Multiplate analyzer, Verum Diagnostica, Munich) as a point-of-care (POC) device in adult cardiac surgical patients.
Mini-Extracorporeal Circulation Minimizes Coagulation Abnormalities and Ameliorates Pulmonary Outcome in Coronary Artery Bypass Grafting Surgery
Our study suggests that MECC induces less coagulation disorders, leading to lower postoperative blood loss and better postoperative lung function. This approach may be advantageous in high-risk patients.
The Relationship Between Intraoperative Blood Transfusion and Postoperative Systemic Inflammatory Response Syndrome
Previous observations suggest that intraoperative blood transfusion (IBT) is a risk factor for adverse postoperative outcomes. IBT alters immune function and may predispose to systemic inflammatory response syndrome (SIRS).
Perfusion Tubing: Standardized or Modify?
I applaud our adult colleagues in trying to do what is best for the patient even if standardized tubing packs have to be modified resulting in higher prices as some would argue.
Transcatheter Aortic Valve Replacement Requiring Staged Percutaneous Coronary Intervention in Japanese Patients with Severely Calcified Ascending Aorta: A Case Report and Institution Series Analysis
We report a first TAVR case in Japan of successful TAVR following percutaneous coronary intervention (PCI). A 75-year-old man with stable angina pectoris and severe AS was considered to be at high risk for surgical AVR because of severely calcified ascending aorta.
The ATHENS TAVR Registry of Newer Generation Transfemoral Aortic Valves: 30-Day Outcomes
Transcatheter aortic valve replacement (TAVR) is a documented treatment for patients with symptomatic aortic stenosis who are at very high or prohibitive operative risk. We sought to investigate the outcomes of transfemoral procedures with the newer generation valves in four TAVR centres in Athens, Greece.